BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16881851)

  • 1. Effect of mitotane on pituitary corticotrophs in clinically normal dogs.
    Taoda T; Hara Y; Takekoshi S; Itoh J; Teramoto A; Osamura RY; Tagawa M
    Am J Vet Res; 2006 Aug; 67(8):1385-94. PubMed ID: 16881851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trilostane-induced inhibition of cortisol secretion results in reduced negative feedback at the hypothalamic-pituitary axis.
    Teshima T; Hara Y; Takekoshi S; Nezu Y; Harada Y; Yogo T; Teramoto A; Osamura RY; Tagawa M
    Domest Anim Endocrinol; 2009 Jan; 36(1):32-44. PubMed ID: 19041802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo correlation between c-Fos expression and corticotroph stimulation by adrenocorticotrophic hormone secretagogues in rat anterior pituitary gland.
    Takigami S; Fujiwara K; Kikuchi M; Yashiro T
    Cell Tissue Res; 2008 Mar; 331(3):589-94. PubMed ID: 18092182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function.
    Gentilin E; Tagliati F; Terzolo M; Zoli M; Lapparelli M; Minoia M; Ambrosio MR; Degli Uberti EC; Zatelli MC
    J Endocrinol; 2013 Sep; 218(3):275-85. PubMed ID: 23814013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the urine cortisol-to-creatinine ratio for monitoring dogs with pituitary-dependent hyperadrenocorticism during induction treatment with mitotane (o,p'-DDD).
    Randolph JF; Toomey J; Center SA; Scarlett JM; Reimers T; Graham P; Nachreiner RF
    Am J Vet Res; 1998 Mar; 59(3):258-61. PubMed ID: 9522940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of urine cortisol:creatinine ratio versus adrenocorticotropic hormone stimulation testing for monitoring mitotane treatment of pituitary-dependent hyperadrenocorticism in dogs.
    Angles JM; Feldman EC; Nelson RW; Feldman MS
    J Am Vet Med Assoc; 1997 Oct; 211(8):1002-4. PubMed ID: 9343543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ghrelin stimulates adrenocorticotrophic hormone (ACTH) secretion by human ACTH-secreting pituitary adenomas in vitro.
    Pecori Giraldi F; Bucciarelli LG; Saccani A; Scacchi M; Pesce S; Losa M; Cavagnini F
    J Neuroendocrinol; 2007 Mar; 19(3):208-12. PubMed ID: 17280594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenal steroid hormone concentrations in dogs with hair cycle arrest (Alopecia X) before and during treatment with melatonin and mitotane.
    Frank LA; Hnilica KA; Oliver JW
    Vet Dermatol; 2004 Oct; 15(5):278-84. PubMed ID: 15500479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year follow-up evaluation of magnetic resonance imaging of the brain in dogs with pituitary-dependent hyperadrenocorticism.
    Bertoy EH; Feldman EC; Nelson RW; Dublin AB; Reid MH; Feldman MS
    J Am Vet Med Assoc; 1996 Apr; 208(8):1268-73. PubMed ID: 8635969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of corticotrophin-releasing hormone on corticotrophs in anterior pituitary gland allografts in hypophysectomized, orchidectomized hamsters.
    Horacek MJ; Campbell GT; Blake CA
    Cell Tissue Res; 1989 Oct; 258(1):65-8. PubMed ID: 2553264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of the androgen receptor in the diencephalon and the pituitary gland in goats: Co-localisation with corticotrophin releasing hormone, arginine vasopressin and corticotrophs.
    Maejima Y; Aoyama M; Ookawara S; Hirao A; Sugita S
    Vet J; 2009 Aug; 181(2):193-9. PubMed ID: 18474445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of adrenal gland dependent hyperadrenocorticism with mitotane therapy in a Yorkshire terrier dog.
    Lee YM; Kang BT; Jung DI; Park C; Kim HJ; Kim JW; Lim CY; Park EH; Park HM
    J Vet Sci; 2005 Dec; 6(4):363-6. PubMed ID: 16294004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo temporal aspects of ACTH secretion: stimulatory actions of corticotropin-releasing hormone and vasopressin in cattle.
    Carroll JA; McArthur NH; Welsh TH
    J Vet Med A Physiol Pathol Clin Med; 2007 Feb; 54(1):7-14. PubMed ID: 17359448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oral administration of controlled-ileal-release budesonide and assessment of pituitary-adrenocortical axis suppression in clinically normal dogs.
    Stroup ST; Behrend EN; Kemppainen RJ; Smith-Carr S
    Am J Vet Res; 2006 Jul; 67(7):1173-8. PubMed ID: 16817739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 125I-Tyr0-hCRH labelling characteristics of corticotropin-releasing hormone receptors: differences between normal and adenomatous corticotrophs.
    Abs R; Smets G; Vauquelin G; Verhelst J; Mahler C; Verlooy J; Stevenaert A; Wouters L; Borgers M; Beckers A
    Neurochem Int; 1997 Mar; 30(3):291-7. PubMed ID: 9041560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of melanotroph- and corticotroph-type proopiomelanocortin derivatives into blood after administration of corticotropin-releasing hormone in patients with septic shock without adrenocortical insufficiency.
    Matejec R; Löcke G; Mühling J; Harbach HW; Langefeld TW; Bödeker RH; Hempelmann G
    Shock; 2009 Jun; 31(6):553-60. PubMed ID: 18827746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-specific effects of perinatal glucocorticoid treatment on anterior pituitary morphology, annexin 1 expression and adrenocorticotrophic hormone secretion in the adult female rat.
    John CD; Theogaraj E; Christian HC; Morris JF; Smith SF; Buckingham JC
    J Neuroendocrinol; 2006 Dec; 18(12):949-59. PubMed ID: 17076770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the urine cortisol: creatinine ratio to monitor treatment response in dogs with pituitary-dependent hyperadrenocorticism.
    Guptill L; Scott-Moncrieff JC; Bottoms G; Glickman L; Johnson M; Glickman N; Nelson R; Bertoy E
    J Am Vet Med Assoc; 1997 Apr; 210(8):1158-61. PubMed ID: 9108922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of mitotane therapy in dogs with pituitary dependent Cushing syndrome on the adrenal gland size--an ultrasonographic study].
    Hörauf A; Reusch C
    Schweiz Arch Tierheilkd; 1999; 141(5):239-45. PubMed ID: 10354742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of corticotropin-releasing hormone as a thyrotropin-releasing factor in non-mammalian vertebrates.
    De Groef B; Van der Geyten S; Darras VM; Kühn ER
    Gen Comp Endocrinol; 2006 Mar; 146(1):62-8. PubMed ID: 16337947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.